4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-24-024936
PRESIDENT AND CEO sold 20,000 shares at an average $53.29 ($1,065,743)
- PRESIDENT AND CEO acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Torley Helen PRESIDENT AND CEO | 2024-10-08 | Option exercise 10b5-1 | +10,000 | $13.87 | $138,700 | 686,744 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-08 | Sale 10b5-1 | −9,100 | $53.94 | $490,845 | 677,644 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-08 | Sale 10b5-1 | −900 | $54.57 | $49,116 | 676,744 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-09 | Option exercise 10b5-1 | +10,000 | $13.87 | $138,700 | 686,744 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-09 | Sale 10b5-1 | −5,981 | $51.85 | $310,097 | 680,763 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-09 | Sale 10b5-1 | −1,615 | $53.31 | $86,096 | 679,148 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-09 | Sale 10b5-1 | −2,404 | $53.91 | $129,590 | 676,744 | D |
| Derivatives | |||||||
| Torley Helen PRESIDENT AND CEO | 2024-10-08 | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $138,700 | 10,000 | D |
| Torley Helen PRESIDENT AND CEO | 2024-10-09 | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $138,700 | 0 | D |
| Open-market sales · 20,000 sh · avg $53.29 · $1,065,743 | |||||||
Loading xslF345X05/form4-10092024_091039.xml…